Business
Are CSL shares a buy after the brutal selloff?
Image source: Getty Images
CSL Ltd (ASX: CSL) shares had a day to forget on Tuesday.
The biotechnology giant’s shares ended the session 17% lower at a 52-week low of $225.50.
This was driven by the release of its full year results for FY 2025, which while ahead of consensus estimates, included…
Continue Reading
-
Noosa News24 hours agoADF to introduce billion-dollar drone dome over Brisbane 2032
-
General22 hours agoQueensland government strikes new deal with Bravus to defer royalties, expand Carmichael coal mine
-
Business23 hours agoMacquarie predicts more than 40% upside for this ASX 200 stock
-
General23 hours agoVulnerable youth non-for-profit Allambi Care agrees to end ‘unacceptable’ housing scheme